A nurse is administering pancrelipase to a child who has cystic fibrosis. Which of the following outcomes should the nurse expect as a therapeutic effect of the treatment?

A. Reduced fat in the stools is correct. Pancrelipase is an enzyme replacement therapy that helps improve digestion and absorption of fats and proteins in individuals with cystic fibrosis. This treatment is especially important for those with pancreatic insufficiency, as it helps prevent the steatorrhea (fatty stools) commonly seen in these patients. B. Decreased sodium excretion is incorrect. Pancrelipase does not directly affect sodium balance in the body. Cystic fibrosis patients may experience increased sodium excretion, which requires special management of fluid and electrolytes. C. Improved respiratory function is incorrect. While pancrelipase improves digestion, it does not directly affect respiratory function, which is primarily impacted by the progressive lung disease in cystic fibrosis. D. Improved absorption of vitamins B and C is incorrect. While pancrelipase helps with fat absorption, it primarily improves the absorption of fat-soluble vitamins (A, D, E, K) rather than water-soluble vitamins like B and C.